- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01501045
Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM)
March 26, 2019 updated by: d_yarnitsky, Rambam Health Care Campus
The Effect of Transmagnetic Stimulation on Descending Pain Modulation
While some indications of the neural circuits involved in the Conditioned Pain Modulation (CPM) process are now available, there is still need to clarify what parts of the brain are essential for this process, whether the spino-brainstem loop is largely sufficient to explain CPM or whether other cerebral and spinal regions such as frontal, somatosensory and other cortical regions contribute substantially.
Whereas mere observation of correlation between these circuits while activated by brain imaging is still of considerable interest, direct experimental manipulations by repetitive transcranial magnetic stimulation (rTMS) could even establish insights into causal relationships.
Study Overview
Status
Completed
Detailed Description
rTMS of different intensities, frequencies and location will be applied during CPM to evaluate the central mechanisms of pain modulation, their location and role in pain reduction through enhancement or suppression of activity in the relevant brain regions.
In other words, cortical regions that may be implicated in CPM will be determined by augmenting or interrupting their activity via rTMSapplied to the areas under investigation.
The regions will be the pain network sites, which are assumed to control the top-down influence on CPM and are superficial enough to be stimulated by the magnetic coil.
These include primarily DLPFC (dorsolateral prefrontal cortex) and OFC (orbitofrontal cortex), with possible later addition of other relevant sites such as ACC (anterior cortex cinguli), insula and somatosensory cortices, etc.
Since rTMS may be administered in a manner that either reduces or enhances the excitability of the stimulated cortical region, it should be possible to clarify the inhibitory or excitatory role of these regions in the CPM process.
In summary, the planned studies should allow for identifying the cortical regions of the descending pain system, which are critical as starting points for the top-down modulation of CPM.
Study Type
Interventional
Enrollment (Actual)
94
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- The lab of clinical neurophysiology, the faculty of medicine, Technion and Rambam Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18-70
- males and females
- right handed
Exclusion Criteria:
- metal in brain/skull
- cardiac pacemaker
- cohlear implants
- history of head trauma
- history of epilepsy or seizures
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: healthy subjects
|
repeated TMS (rTMS)
Other Names:
repeated TMS
Other Names:
|
EXPERIMENTAL: pain patients
Migraine and muscle headache patients
|
repeated TMS (rTMS)
Other Names:
repeated TMS
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain scores as measured by pain numerical scale (NPS)
Time Frame: 1 week
|
TMS directed to pain inhibitory cortical areas will evoke pain reduction
|
1 week
|
Amplitude of pain-evoked potentials
Time Frame: 1 week
|
Change in pain evoked potentials will be assessed before and after the TMS
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
conditioned pain modulation (CPM)
Time Frame: 1 week
|
Change in the efficiency of CPM will be assessed in response to TMS
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2011
Primary Completion (ACTUAL)
November 6, 2017
Study Completion (ACTUAL)
November 6, 2017
Study Registration Dates
First Submitted
December 12, 2011
First Submitted That Met QC Criteria
December 28, 2011
First Posted (ESTIMATE)
December 29, 2011
Study Record Updates
Last Update Posted (ACTUAL)
March 27, 2019
Last Update Submitted That Met QC Criteria
March 26, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TMS-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Tonix Pharmaceuticals, Inc.PremierCompletedChronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura MigraineUnited States
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaboratorsRecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With AuraItaly
-
CoolTech LLCTerminatedMigraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaboratorsRecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With AuraItaly
-
Notre-Dame Hospital, Montreal, Quebec, CanadaAllerganCompletedChronic Migraine | Migraine Without Aura | Migraine With AuraCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraDenmark
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...CompletedMigraine With Aura | Migraine in ChildrenItaly
-
The Cleveland ClinicWithdrawnMigraine | Migraine Disorders | Headache Disorders, Primary | Migraine Headache | Migraine Without Aura | Migraine With Aura | Headache, MigraineUnited States
Clinical Trials on TMS system MagPro x100, Tonica Elektronik A/S, Denmark
-
Centre for Addiction and Mental HealthUniversity Health Network, TorontoCompletedDepressive Disorder | Schizophrenia | Schizoaffective Disorder | Obsessive-Compulsive DisorderCanada
-
University of British ColumbiaRecruitingDepression | Parkinson Disease | Movement Disorders | Major Depressive DisorderCanada
-
Wuerzburg University HospitalUniversity of WuerzburgCompleted
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)WithdrawnDepressive DisorderCanada
-
Centre for Addiction and Mental HealthCompletedMajor Depressive DisorderCanada
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedMajor Depressive DisorderCanada
-
Centre for Addiction and Mental HealthCompletedSchizophreniaCanada
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)Completed
-
Centre for Addiction and Mental HealthAcademic Health Science CentresCompleted
-
Stanford UniversityNational Institutes of Health (NIH); National Center for Complementary and...CompletedFibromyalgiaUnited States